Natural Product: NPC603832

Natural Product IDNPC603832
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
SMBRHXBVGDCQRG-HOSUYAQASA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL1095016
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey SMBRHXBVGDCQRG-HOSUYAQASA-N
Standard InCHI InChI=1S/C46H72O17/c1-9-21(2)38(58)63-36-35(55)46(20-49)23(16-41(36,3)4)22-10-11-26-42(5)14-13-28(43(6,19-48)25(42)12-15-44(26,7)45(22,8)17-27(46)50)60-40-32(54)33(31(53)34(62-40)37(56)57)61-39-30(52)29(51)24(18-47)59-39/h9-10,23-36,39-40,47-55H,11-20H2,1-8H3,(H,56,57)/b21-9-/t23-,24-,25+,26+,27+,28-,29-,30+,31-,32+,33-,34-,35-,36-,39-,40+,42-,43+,44+,45+,46-/m0/s1
SMILES C/C=C(/C)C(=O)O[C@H]1[C@H](O)[C@]2(CO)[C@H](O)C[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O[C@@H]7O[C@@H](CO)[C@H](O)[C@H]7O)[C@H]6O)[C@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2CC1(C)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   896.48 Volume:   883.165
?
Van der Waals volume.
Dense:   1.015 LogP:   1.52
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.172
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.816
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   11.0 Rigid Bonds:   40.0
TPSA:   282.59
?
Topological Polar Surface Area.
H-Bond Acceptor:   17.0
H-Bond Donor:   10.0 Rings:   7.0
Heavy Atoms:   17.0

MedChem Properties

QED Drug-Likeness Score:   0.063 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   6.345 Fsp3:   0.87
MCE-18:   157.791
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.784 Fluc inhibitor:   0.003
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.003
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.0
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.21 Promiscuous compounds:   0.228

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.406 MDCK Permeability:   -5.167
Pgp-inhibitor:   0.0 Pgp-substrate:   0.354
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.004
20% Bioavailability (F20%):   0.967 30% Bioavailability (F30%):   0.752
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.801 MRP1:   0.969
Plasma Protein Binding (PPB):   75.625% Volume Distribution (VD):   -0.54
Fu: 17.593%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.765
OATP1B3 inhibitor:   0.001 BCRP inhibitor:   0.005
BSEP inhibitor:   0.025

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.002 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.001
HLM stability:   0.001
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  0.266 Half-life (T1/2):  2.321

ADMET: Toxicity

hERG Blockers:  0.001 hERG Blockers (10um):  0.004
Human Hepatotoxicity (H-HT):  0.507 Drug-induced Liver Injury (DILI):  0.92
AMES Toxicity:  0.886 Rat Oral Acute Toxicity:  0.253
Maximum Recommended Daily Dose:  0.039 Skin Sensitization:  1.0
Carcinogencity:  0.537 Eye Corrosion:  0.0
Eye Irritation:  0.003 Respiratory Toxicity:  0.123
Drug-induced Neurotoxicity:  0.004 Ototoxicity:  0.985
Hematotoxicity:  0.851 Drug-induced Nephrotoxicity:  0.997
Genotoxicity:  0.966 RPMI-8226 Immunitoxicity:  0.151
A549 Cytotoxicity:  0.949 Hek293 Cytotoxicity:  0.575
BCF:   0.364
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.367
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.202
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.005
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8706 Aesculus pavia Species Sapindaceae Eukaryota n.a. n.a. n.a. PMID[17914881]
NPO8706 Aesculus pavia Species Sapindaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO8706 Aesculus pavia Species Sapindaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1044 Individual protein DNA topoisomerase II alpha Homo sapiens IC50 > 250000.0 nM PMID[20371180]
NPT143 Individual protein DNA topoisomerase I Homo sapiens Inhibition n.a. n.a. % PMID[20371180]
NPT143 Individual protein DNA topoisomerase I Homo sapiens IC50 = 23800.0 nM PMID[20371180]
NPT143 Individual protein DNA topoisomerase I Homo sapiens Activity n.a. n.a. n.a. PMID[20371180]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT306 Cell line PC-3 Homo sapiens GI50 = 5510.0 nM PMID[20371180]
NPT116 Cell line HL-60 Homo sapiens GI50 = 7500.0 nM PMID[20371180]
NPT81 Cell line A549 Homo sapiens GI50 = 12920.0 nM PMID[20371180]
NPT461 Cell line PANC-1 Homo sapiens GI50 = 10350.0 nM PMID[20371180]
NPT171 Cell line MRC5 Homo sapiens GI50 = 15380.0 nM PMID[20371180]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC603832 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7551 Intermediate Similarity NPC603870
0.7182 Intermediate Similarity NPC609119
0.7091 Intermediate Similarity NPC472267
0.7091 Intermediate Similarity NPC115656
0.7037 Intermediate Similarity NPC477191
0.6838 Remote Similarity NPC476774
0.6759 Remote Similarity NPC611191
0.6667 Remote Similarity NPC478597
0.6555 Remote Similarity NPC478596
0.6518 Remote Similarity NPC477193
0.6518 Remote Similarity NPC477192
0.6404 Remote Similarity NPC477195
0.6348 Remote Similarity NPC477196
0.6167 Remote Similarity NPC252289
0.6167 Remote Similarity NPC305793
0.6146 Remote Similarity NPC258547
0.6042 Remote Similarity NPC283343
0.6034 Remote Similarity NPC477194
0.6032 Remote Similarity NPC476775
0.5983 Remote Similarity NPC605294
0.5966 Remote Similarity NPC478600
0.5966 Remote Similarity NPC478599
0.5932 Remote Similarity NPC25998
0.5827 Remote Similarity NPC11577
0.5827 Remote Similarity NPC141600
0.5798 Remote Similarity NPC107536
0.5798 Remote Similarity NPC280029
0.5798 Remote Similarity NPC9470
0.5726 Remote Similarity NPC82380
0.5726 Remote Similarity NPC244296
0.5714 Remote Similarity NPC11242
0.5691 Remote Similarity NPC269484
0.5691 Remote Similarity NPC97918
0.568 Remote Similarity NPC478598
0.5635 Remote Similarity NPC476780
0.56 Remote Similarity NPC329828
0.5574 Remote Similarity NPC478155
0.5565 Remote Similarity NPC159309
0.5565 Remote Similarity NPC86222
0.5455 Remote Similarity NPC477197
0.5455 Remote Similarity NPC476778
0.5447 Remote Similarity NPC1314
0.5447 Remote Similarity NPC273878
0.5447 Remote Similarity NPC478154
0.544 Remote Similarity NPC602995
0.5414 Remote Similarity NPC476776
0.5378 Remote Similarity NPC114484
0.5345 Remote Similarity NPC605226
0.5312 Remote Similarity NPC470518
0.5312 Remote Similarity NPC21691
0.5242 Remote Similarity NPC252657
0.5242 Remote Similarity NPC88311
0.5234 Remote Similarity NPC4749
0.5231 Remote Similarity NPC271610
0.5185 Remote Similarity NPC224121
0.5154 Remote Similarity NPC265841
0.5152 Remote Similarity NPC476777
0.5122 Remote Similarity NPC329976
0.5086 Remote Similarity NPC473884
0.5076 Remote Similarity NPC484059
0.5076 Remote Similarity NPC484060
0.5076 Remote Similarity NPC476779

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC603832 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data